Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.

about

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis

P2860

Q47216784-10A93D18-5D90-484C-8142-4E9F303ADBFD Q58551068-F5A60793-8D46-4B09-B18E-49EDF7104C08

P2860

Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.

Item

http://www.wikidata.org/entity/Q50951302

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Asymmetric Dimethylarginine Co ...... Erythropoietin in CKD-Anemia.

@en

Asymmetric Dimethylarginine Co ...... Erythropoietin in CKD-Anemia.

@nl

type

Item

label

Asymmetric Dimethylarginine Co ...... Erythropoietin in CKD-Anemia.

@en

Asymmetric Dimethylarginine Co ...... Erythropoietin in CKD-Anemia.

@nl

prefLabel

Asymmetric Dimethylarginine Co ...... Erythropoietin in CKD-Anemia.

@en

Asymmetric Dimethylarginine Co ...... Erythropoietin in CKD-Anemia.

@nl

P1476

Asymmetric Dimethylarginine Co ...... o Erythropoietin in CKD-Anemia

@en

P2093

Junko Yano

http://www.w3.org/2001/XMLSchema#string

Kei Fukami

http://www.w3.org/2001/XMLSchema#string

Kensei Taguchi

http://www.w3.org/2001/XMLSchema#string

Masumi Kimoto

http://www.w3.org/2001/XMLSchema#string

Miki Sugiyama

http://www.w3.org/2001/XMLSchema#string

Miyuki Yokoro

http://www.w3.org/2001/XMLSchema#string

Ryotaro Ando

http://www.w3.org/2001/XMLSchema#string

Sakuya Ito

http://www.w3.org/2001/XMLSchema#string

Seiji Ueda

http://www.w3.org/2001/XMLSchema#string

Sho-Ichi Yamagishi

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of erythroferrone as an erythroid regulator of iron metabolism

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomes

Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.

Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1.

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial

Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.

Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney.

Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.

P304

2670-2680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2016111184

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daisuke Saigusa

P577

2017-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28600471

http://www.w3.org/2001/XMLSchema#string

P921

Erythropoietin

P932

5576934

http://www.w3.org/2001/XMLSchema#string

Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.

about

P2860

P2860

Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932